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Purpose: To investigate the genetic association between unrelated Korean keratoconus patients and interleukin 1 alpha
(IL1A), interleukin 1 beta (IL1B), and IL1 receptor antagonist (IL1RN) gene polymorphisms.
Methods: We investigated the association between  IL1A (rs1800587, rs2071376, and  rs17561), IL1B (rs1143627,
rs16944, rs1143634, and rs1143633), and IL1RN (rs419598, rs423904, rs424078, and rs315952, variable number tandem
repeat [VNTR]) polymorphisms in 100 unrelated Korean keratoconus patients. One hundred control individuals without
any corneal disease were selected from the general population. Polymerase chain reaction (PCR) – restriction fragment
length polymorphism (RFLP) analysis and direct sequencing were used to screen for genetic variations in the IL1 gene
cluster. Haplotypes for the IL1 gene cluster were constructed using Haploview version 4.0.
Results: We analyzed a total of 12 polymorphic sites in the IL1 gene cluster. Among them, the −511 (rs16944) and −31
(rs1143627) positions in the promoter region of IL1B were significantly different between patient and control groups. The
C allele of rs16944 (−511C>T, p=0.022, odds ratio of risk [OR]=1.46, 95% confidence intervals [CI] 0.94<2.27) and the
T allele of rs1143627 (−31T>C, p=0.025, OR=1.43, 95% CI 0.92<2.22) were associated with a significantly increased
risk of keratoconus in Korean patients. Linkage of the two alleles, −31*C and −511*T, was associated with an increased
risk for keratoconus with OR=2.38 (p=0.012, 95% CI=1.116–5.046). The *C/*A genotype of rs2071376 in IL1A intron
6  was  significantly  different  between  the  keratoconus  patients  and  control  subjects  (p=0.034,  OR=0.59,  95%  CI
0.32<1.11). Other polymorphisms did not show an association with keratoconus risk.
Conclusions: This is the first report of IL1 gene cluster mutation screening in Korean keratoconus patients. Significant
differences  in  allelic  frequency  of  IL1B  between  keratoconus  patients  and  the  control  group  suggest  that  IL1B
polymorphisms may play a role in the susceptibility of unrelated Koreans to develop keratoconus.
Keratoconus (OMIM 148300) is a bilateral, asymmetric,
chronic, progressive ectasia of the cornea characterized by the
steepening and distortion of the cornea, thinning of the apical
cornea,  and  corneal  scarring,  which  leads  to  progressive
myopic and irregular astigmatism [1-3]. Histologically, the
keratoconic cornea stroma may become less than one-quarter
its normal thickness thereby leading to extensive distortion
[4].  The  pathophysiological  processes  underlying  the
keratoconic cornea have yet to be fully elucidated, although
various studies have suggested that keratoconus is associated
with eye rubbing in atopic patients [2,5], contact lens wearing
[6], increased proteinase activity [4,7], decreased levels of
proteinase  inhibitors  [8-10],  increased  oxidative  damage
[11], and keratocyte apoptosis [12,13].
Keratocyte  apoptosis  has  been  reported  in  60%  of
keratoconic corneas and is triggered by the epithelial release
of  interleukin  1  (IL1),  which  is  activated  by  chronic
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mechanical injury to the corneal epithelium [12,14]. More
specifically, IL1 has been implicated as a damage mediator,
which is a modulator that regulates the apoptotic process [15,
16], in these eye rubbers. In addition, stromal thinning in
keratoconus  is  caused  by  the  stimulation  of  keratocyte
apoptosis induced by IL1. For these reasons, IL1 has been
suggested as a candidate gene for keratoconus.
IL1  is  a  pleiotropic  cytokine.  It  is  involved  in  the
inflammatory response, cell growth, and tissue repair in the
cortex. The IL1 superfamily consists of three members, IL1
alpha (IL1α), IL1 beta (IL1β, predominant form) and IL1
receptor  antagonist  (IL1Ra),  which  are  encoded  by  IL1A,
IL1B, and IL1RN, respectively [17,18]. The IL1 superfamily
genes are located in tandem in a cluster on chromosome 2q14.
This  gene  cluster  contains  several  polymorphisms  [19].
Among them, some polymorphisms are located within the
regulatory  regions  of  the  genes.  Their  localization  in
regulatory  regions  suggests  that  they  may  modulate  IL1
protein production by directly affecting transcription, leading
to their association with altered levels of IL1 [18,20-22].
The  goal  of  this  study  was  to  elucidate  whether
polymorphisms in IL1A, IL1B, and IL1RN are associated with
keratoconus in Korean patients. We determined the genotype
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2109frequencies of 11 single nucleotide polymorphisms (SNPs),
which were associated with altered levels of cytokines, and
one variable number tandem repeat (VNTR) marker in the IL1
gene  cluster  in  unrelated  Korean  keratoconus  patients.
Identification of genetic factors that determine susceptibility
to keratoconus in Korean patients may allow us to gain insight
into the pathogenesis of keratoconus.
METHODS
This study included 100 unrelated keratoconus patients of
Korean descent with age ranging from 18 to 33 years old. All
of the keratoconus patients were identified from the Korea Eye
Tissue and Gene Bank related to Blindness in the Department
of Ophthalmology at the Catholic University of Korea (Seoul,
Korea).  Appropriate  informed  consent  was  obtained  from
each subject, and all studies were performed according to the
tenets  of  the  Declaration  of  Helsinki.  The  patients  were
diagnosed with keratoconus based on the following criteria:
(1)  symptoms  of keratoconus  including the  Munson  sign,
protrusion,  Vogt’s  striae,  corneal  thickness,  scarring,  the
Fleischer  ring,  signs  of  photokeratoscopy,  signs  of
videokeratography,  and  refractive  errors  and  (2)  medical
histories including age, sex, contact lens use, eye rubbing
behavior,  systemic  disease,  atopy,  and  connective  tissue
disease [2,23]. One hundred age-matched control individuals
with no history of keratoconus were also enrolled from the
Korea Eye Tissue and Gene Bank related to Blindness.
DNA was extracted from peripheral blood samples using
the  QIAamp  DNA  blood  kit  (QIAGEN,  Valencia,  CA).
Polymerase chain reaction (PCR) reactions were performed
with 25 ng of genomic DNA as a template in a mixture of PCR
buffer, 2.5 mM MgCl2, 200 nM dNTPs, 0.4 pmol of each
primer,  and  0.75  units  of  h-Taq  polymerase  (Solgent,
Daejeon, Korea; Table 1) [19,24,25].
Biallelic polymorphisms in the IL1 gene cluster were
determined  by  PCR–restriction  fragment  length
polymorphism (RFLP) analysis and direct sequencing (Table
1).  The  IL1RN  VNTR  polymorphism  was  evaluated  by
identifying the number of repeats in the (86)n sequence using
agarose gel electrophoresis and direct sequencing [19,24,25].
The Hardy–Weinberg equilibrium (HWE) was calculated
using the GenePop web version 4.0 program. To determine
statistically  significant  differences  in  genotype  and  allele
frequencies between the two groups, we used the χ2 test or
Fisher’s exact test for the 2×2 contingency table file. The
descriptive  statistics  for  observed  differences  in  allele  or
genotype distribution with the corresponding p values were
analyzed using the JavaStat web software in combination with
StatXact-8  software  (Cytel  Inc.,  Cambridge,  MA).  The
strength of the association was estimated by odds ratio of risk
(OR)  and  95%  confidence  intervals  (CI).  Haplotype
frequencies and associations were calculated with Haploview
(version 4.0) that uses the expectation maximization (EM)
algorithm [26]. Haplotype distributions were evaluated by the
permutation test on the basis of 10,000 replications to obtain
the  empirical  significance  [26].  Values  of  p<0.05  were
considered statistically significant.
RESULTS
We analyzed 11 SNPs and one VNTR marker in the IL1 gene
cluster:  rs1800587,  rs2071376,  and  rs17561  for  IL1A;
rs1143627, rs16944, rs1143634, and rs1143633 for IL1B; and
rs419598,  rs423904,  rs424078,  rs315952,  and  the  (86)n
VNTR marker for IL1RN (Figure 1). The IL1A, IL1B, and
IL1RN  genotypic  and  allelic  frequencies  in  keratoconus
patients  are  listed  in  Table  2  and  Table  3.  The  genotype
distributions of the variants of the 12 polymorphisms in the
TABLE 1. POLYMORPHIC SITES OF IL1A, IL1B, AND IL1RN.
Nucleotide                    SNPs
Amino
dbSNPs                   acid
Assay
methoda Genotypesb
IL1A
exon 1 −889 C>T Ex1+12C>T rs1800587 RFLP: DpnII *c: 170bp *t: 145+25bp
exon 5 +4845 G>T Ex5+21G>T rs17561 A114S RFLP: SatI *G:29+123+3+84bp *T:152+3+84bp
intron 6 +376 C>A IVS6+169C>A rs2071376 RFLP: BstYI *c:270bp *a: 198+72bp
IL1B
promoter −511C>T −511T>C rs16944 RFLP: AvaI *t:530bp *c:190+340bp
promoter −31 T>C −31 C>T rs1143627 Direct
sequencing
intron 4 +5810 G>A IVS4–64G>A rs1143633 RFLP: Fnu4HI *g:38+271+19bp *a:309+19bp
exon 5 +3954C>T Ex5+14C>T rs1143634 F105F RFLP: TaqI *C:116+212bp *T:328bp
IL1RN
exon 4 +8006 C>T EX4+55C>T rs419598 A60A RFLP: HpaII *C: 29 +98 bp *T: 127 bp
intron 4 +8061 C>T IVS4+21C>T rs423904 RFLP: MwoI *c:179+46bp *t:225bp
intron 4 86bp VNTR Agarose I: 410 bp, II: 240bp, III:
500bp, IV: 325 bp, V: 595 bp
intron 5 +9589A>T IVS5+59A>T rs454078 RFLP: SspI *a:299bp *t:145+154bp
exon 7 +11100T>C Ex7+72T>C rs315952 S133S RFLP: MspA1I *T:330bp *C:132+198bp
Assay methoda: Screening method for polymorphic site and lists of restriction enzyme; Agarose: Agarose gel electrophoresis;
Genotypesb: It was indicated restricted sizes by RFLP analysis and amplified products for VNTR.
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2110IL1  gene  cluster  among  the  control  subjects  and  the
keratoconus patients were in Hardy–Weinberg equilibrium.
Of the four SNPs in IL1B, the rs1143627 (−31T>C) and
rs16944 (−511C>T) positions in the promoter region of IL1B
Figure  1.  IL1A,  IL1B,  and  IL1RN,
showing  polymorphic  nucleotide
sequences. The map of the three genes,
which are located on 2q14, is according
to the UCSC Human Genome Browser
Mar 2006 Assembly. The direction of
transcription is shown above each gene
by a horizontal arrow. Exons are shown
as  rectangles.  Vertical  lines  indicate
polymorphic  sites  evaluated  in  this
study.
TABLE 2. GENOTYPE FREQUENCIES OF IL1A AND IL1B IN KERATOCONUS PATIENTS.
Genes SNPs
Frequency (%)
Genotypes                  Keratoconus Control                   p value
IL1A −889 C>T (rs1800587) C/C 87.2 88.6 N.S.
T/C 11.7 10 N.S.
T/T 1.1 1.4 N.S.
+4845 G>T (rs17561) G/G 75.8 81.4 N.S.
T/G 23.2 17.1 N.S.
T/T 1.1 1.4 N.S.
+376 C>A (rs2071376) A/A 11.7 8.6 N.S.
C/A 37.2 50 0.034*
C/C 51.1 41.4 N.S.
IL1B −511C>T (rs16944) 34.8 21.4 0.025**
T/C 43.5 51.5 N.S.
T/T 21.7 27.1 N.S.
−31 T>C(rs1143627) C/C 23.7 28.6 N.S.
T/C 41.9 50 N.S.
T/T 34.4 21.4 0.027***
+5810G>A (rs1143633) A/A 39.8 45.7 N.S.
G/A 39.8 35.7 N.S.
G/G 20.4 18.6 N.S.
+3954C>T (rs1143634) C/C 92.5 95.7 N.S.
T/C 6.5 2.9 N.S.
T/T 1.1 1.4 N.S.
The asterisk indicates that OR=0.59 and 95% CI=0.32<1.11. The double asterisk indicates that OR=1.96 and 95% CI=0.96<3.96.
The triple asterisk indicates that OR=1.92 and 95% CI=0.95<3.90. N.S., not significant.
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C/Cwere significantly different between the patient and control
groups. For rs16944 (−511 T>C), the frequency of the *C/*C
genotype was higher in the patients (34.8%) than in control
subjects (21.4%; p=0.025, OR=1.96, 95% CI 0.96<3.96). The
*C allele frequency at rs16944 was also higher in the patients
(56.5%)  than  in  the  control  subjects  (47.1%;  p=0.022,
OR=1.46, 95% CI 0.94<2.27). The distribution of rs1143627
(−31C>T) *T/*T, *T/*C, and *C/*C genotype frequencies
were  34.4,  41.9,  and  23.7,  respectively,  in  keratoconus
patients and  21.4,  50.0,  and  28.6,  respectively,  in  control
subjects. The *T/*T genotype frequency had a higher risk of
occurring  in  keratoconus  patients  than  in  control  subjects
(p=0.027, OR=1.92, 95% CI 0.95<3.90). The allele frequency
of *T was 55.4% in keratoconus patients and 46.4% in control
subjects (p=0.025, OR=1.43, 95% CI 0.92<2.22).
Of  the  three  SNPs  in  IL1A,  the  *C/*A  genotype  for
rs2071376 in intron 6 was significantly different between
keratoconus patients and control subjects (p=0.034, OR=0.59,
95%  CI  0.32<1.11),  but  the  allele  frequencies  were  not
significantly different between the groups. Other SNPs and
the VNTR showed no significant genotype or allele frequency
differences  between  keratoconus  patients  and  control
subjects.
In the haplotype analysis, we identified three haplotype
block  sets,  rs2071376-rs17561-rs1800587-rs1143634  for
Block  A,  rs1143627-rs16944  for  Block  B,  and  rs419598-
rs423904-rs454078  for  Block  C  (Figure  2).  The  T-C
haplotype in Block B was more prevalent in keratoconus
patients than in control subjects and was associated with a
higher risk of developing keratoconus (p=0.034, OR=1.58,
95% CI 1.018<2.448). In contrast, the T-T haplotype in Block
B was less frequent in the keratoconus group compared with
the control group (p=0.009; Table 4).
DISCUSSION
Keratoconus is an abnormality of the interactive epithelial-
stromal system that causes a shift in the delicate balance
between keratocyte proliferation and apoptosis [12]. Using the
TUNEL assay, Kim et al. [12] confirmed the presence of
keratocyte apoptosis in keratoconus corneas and the absence
of  keratocyte  apoptosis  in  normal  corneas.  Keratocyte
apoptosis may be triggered by increased basal IL1 release
[12,14,27]. Previous studies indicated that corneal fibroblasts
from keratoconus patients express about three times more
IL1A mRNA than those from a normal cornea [15,28]. Zhou
et al. [29] reported that the IL1 protein level was higher in the
epithelium and endothelium of the keratoconus corneas than
in normal corneas. In addition, IL1 upregulates keratocyte
expression  of  collagenases,  metalloproteinases,  and  other
enzymes [30,31]. These enzymes have important roles in the
remodeling of collagen during corneal wound healing. For
TABLE 3. GENOTYPE FREQUENCIES OF IL1RN IN KERATOCONUS PATIENTS.
Gene SNP
Frequency (%)
Genotypes                   Keratoconus Control                    p value
IL1RN +8006 C>T(rs419598) C/C 2.1 0.0 N.S.
T/C 11.6 12.9 N.S.
T/T 86.3 87.1 N.S.
+8061 C>T (rs423904) C/C 86.2 87.1 N.S.
T/C 11.7 12.9 N.S.
T/T 2.1 0.0 N.S.
+9589A>T(rs454078) A/A 86.7 85.7 N.S.
T/A 11.1 14.3 N.S.
T/T 2.2 0.0 N.S.
+11100T>C (rs315952) C/C 34.7 34.3 N.S.
T/C 46.3 48.6 N.S.
T/T 19.0 17.1 N.S.
VNTR 1/1 81.5 83.6 N.S.
1/2 13.7 10.0 N.S.
2/2 1.5 0.0 N.S.
3/1 2.6 2.7 N.S.
3/3 0.0 0.9 N.S.
4/1 0.7 2.7 N.S.
N.S., not significant.
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corneal epithelial trauma and increase the release of IL1 [15,
16,32,33]. This would provide a unifying explanation for the
association between keratoconus and factors associated with
mechanical corneal epithelial cell injury such as poorly fitted
rigid contact lenses, excessive eye rubbing, and allergic ocular
surface disease [2,4,5,34]. Therefore, it has been suggested
that interleukins are central modulators of the response to
corneal injury.
The  IL1  superfamily  includes  three  secreted
glycoproteins, IL1α, IL1β, and IL1Ra. Two of these, IL1α and
IL1β, are biologically active while the third member, IL1Ra,
is a receptor antagonist that modulates the effects of IL1α and
IL1β [18,19]. IL1α and IL1β proteins are synthesized by a
Figure 2. Haplotype structure of select
SNPs in IL1A, IL1B, and IL1RN. We
estimated  the  pairwise  linkage
disequilibrium  (LD)  by  calculating
pairwise  D'  and  r2  based  on  marker-
marker  D'>0.70  and  r2>0.80.  The
images  were  generated  with  the
Haploview software pack.
TABLE 4. HAPLOTYPE ANALYSIS OF THE INTERLEUKIN 1 GENES IN KERATOCONUS PATIENTS.
Block
                                         Case:Control
Haplotype                                            frequency χ2 p value
Block 1 rs2071376-rs17561-rs1800587-rs1143634
CGCC 0.656:0.634 0.168 0.682
AGCC 0.217:0.266 1.031 0.309
ATTT 0.042:0.029 0.421 0.516
CTCC 0.041:0.030 0.281 0.596
ATTC 0.032:0.036 0.043 0.836
Block 2 rs1143627-rs16944
TC 0.556:0.442 4.161 0.034*
CT 0.394:0.492 3.176 0.075
CC 0.049:0.029 0.813 0.367
TT 0.001:0.037 6.168 0.009**
Block 3 rs419598-rs423904-rs454078
TCA 0.916:0.929 0.181 0.67
CTT 0.074:0.064 0.11 0.74
The asterisk indicates that OR=1.58 and 95% CI=1.018<2.448, and the double asterisk indicates that OR=0.04 and 95%
CI=0.003<0.667.
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2113variety  of  cell  types  including  activated  macrophages,
stimulated B lymphocytes, fibroblasts, and endothelial cells.
They are powerful mediators of inflammation and the immune
response. IL1A,IL1B, and IL1RN map to human chromosome
2q14. Gene variations that alter gene function are more likely
to influence phenotypic characteristics such as risk of disease
[18]. An in vivo study showed that the IL1A-889 *T allele was
associated  with  increased  IL1α  and  IL1β  protein  levels.
Furthermore, ex vivo analysis of lipopolysaccharide (LPS)-
stimulated peripheral blood mononuclear cells indicated that
production of IL1α from IL1A with the IL1A-889*T allele
increased  [35,36].  The  two  promoter  variants  of  IL1B,
−511C>T  and  −31T>C  SNPs,  have  been  repeatedly
associated with multiple clinical conditions [37,38] such as
cardiovascular disease [39] and gastric cancer [40] as well as
with  clinically  observed  differences  in  the  levels  of  IL1β
protein in vivo [39,41]. The *T allele at −31 in the TATA box
of the IL1B promoter region is suspected to enhance gene
expression and induction of IL1β [42]. The -31 *C allele was
associated with increased IL1β levels and decreased IL1α
levels [43]. It has been reported that the T and C variants at the
IL1B −31 position regulate gene expression and differential
binding of proteins. A specific haplotype, which is composed
of the T allele at −511 and the C allele at −31, was significantly
associated  with  a  twofold  to  threefold  increase  in  LPS-
induced IL1β protein secretion [21]. There was also nearly a
complete  linkage  disequilibrium  between  −511C>T  and
−31T>C in IL1B based on a cis interaction [40,42].
Some  studies  have  suggested  that  the  allelic
polymorphism located within intron 2 of IL1RN play a role in
differential  modulating  IL1  activity.  The  IL1RA*2  is
associated with increased IL1Ra protein production in vitro
[44]. The *C allele of +8006 C/T in exon 2 of IL1RN is
associated with the VNTR allele 2 and is associated with lower
expression of IL1Ra [45,46]. The IL1B-511C, IL1B-31T, and
ILRN+8006T haplotype (C-T-T), which has been associated
with lower levels of IL1β expression [21,38], was present in
the extended protective haplotype. This extended protective
haplotype  contains  the  IL1RN+8006T  allele,  which  is
associated with elevated IL1Ra expression [45]. Therefore,
these studies suggest that IL1 gene cluster polymorphisms
may  affect  susceptibility  to  the  development  of  specific
diseases  and  that  linkage  disequilibrium  of  functional
polymorphisms may indicate increased risk of developing
these diseases.
In the present study, we have reported the results of a
mutation screening of interleukin 1 genes in unrelated Korean
patients  with  keratoconus.  In  the  screen  of  four  SNPs  of
IL1B, the genotypes of –511 *C/*C and –31 *T/*T of IL1B
SNPs were associated with a 1.96 fold and 1.92 fold greater
risk of developing keratoconus, respectively, (p=0.025 and
p=0.027,  respectively),  showing  a  strong  statistical
association with keratoconus in unrelated patients. Two IL1B
SNPs,  −31C/T  and  −511T/C,  have  been  implicated  as
potential  risk  factors  for  keratoconus  among  unrelated
patients. Of the three SNPs in IL1A, the *C/*A genotype of
rs2071376  in  intron  6  differed  significantly  between  the
keratoconus patients and control subjects (p=0.034, OR=0.59,
95%  CI  0.32<1.11),  but  the  allele  frequencies  were  not
significantly different between the groups.
The T-C haplotype of IL1B −31 and –511 was more
prevalent in keratoconus patients than in control subjects and
carried a higher risk of keratoconus (p=0.034, OR=1.58, 95%
CI 1.018<2.448). The T-T haplotype of IL1B −31 and −511
was less frequent in keratoconus patients than in the control
individuals (p=0.009), which was associated with protection.
Our  study  is  the  first  to  report  on  IL1  gene  cluster
polymorphisms in Korean keratoconus patients. We detected
two  disease-associated  SNPs,  rs1143627  (−31T>C)  and
rs16944  (−511C>T),  in  IL1B  and  a  disease-  associated
haplotype,  the  IL1B-31T/-511C  haplotype,  which  is
associated with regulation of IL1α and IL1β production. It
proves  that  IL1  may  have  important  roles  as  central
modulators of keratoconus development. In conclusion, the
present  study  suggests  that  two  SNPs  in  IL1B  predict
keratoconus  predisposition  in  unrelated  Korean  patients,
although  further  research  is  necessary  to  elucidate  the
relationship between the expression levels of IL1α, IL1β, and
IL1Ra and SNPs of IL1B in keratoconus patients.
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